About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Trial using Donated Eye Tissue Could Offer New Hope for Stem Cell Surgery

by Adeline Dorcas on January 29, 2019 at 11:40 AM
Font : A-A+

Trial using Donated Eye Tissue Could Offer New Hope for Stem Cell Surgery

A clinical trial using donated eye tissue could offer new hope for people with sight problems, reports a new study. The findings of the study are published in the journal STEM CELLS Translational Medicine.

Doctors made the world-first step by carrying out a clinical trial using stem cells from donors to create tissue that was transplanted into patients with the condition that causes blindness.

Advertisement


Researchers say the trial offers clues about how eye tissue loss could be repaired using stem cells from organ donors. It also sheds light on the causes of sight disorders.

The trial focused on limbal stem cell deficiency (LSCD), which can result from damage to the eye from chemicals or heat, or be caused by a disease called aniridia. It leads to scarring and severe vision loss in both eyes as well as chronic pain and redness.
Advertisement

LSCD is a significant cause of sight loss - especially in countries where resources and services are limited - but it does not typically respond to standard treatments.

To carry out the trial, researchers - led by the University of Edinburgh and the Scottish National Blood Transfusion Service - isolated stem cells in the eye's protective layer, known as the cornea.

A normal healthy cornea is transparent, but becomes scarred and opaque when specialized stem cells are lost in LSCD.

These cornea samples were taken from people who had donated their eyes after death.

The team then grew the stem cells - which have the unique ability to transform into other cell types - into tissue ready to be transplanted.

Sixteen patients were split into two groups with both given eye drops and medicines to suppress their immune system to reduce transplant rejection. One group was also given the stem cells.

This is the first time that stem cells have been used in this way in a randomized clinical trial - the gold standard scientific method for testing a new treatment.

Patients who had received the stem cells showed significant repair of their eyes' ocular surface - the outermost layer - over 18 months, which was not seen in those who did not receive the treatment.

Both the stem cell group and the control group showed improvements in vision, which researchers say warrants further investigation a larger trial.

Scientists have hailed the step as a landmark for cell-based surgery. They say it shows promise for repairing the eye's surface, paving the way for similar donor trials to be planned.

The team suggest that the immune system could play a driving role in some forms of LSCD, but caution that more research is needed.

The project was funded by UK Stem Cell Foundation, Scottish Enterprise and the Chief Scientist Office, part of Scottish Government Health Directorates.

Baljean Dhillon, Professor of Clinical Ophthalmology at the University of Edinburgh's Centre for Clinical Brain Sciences, who led the study, said: "The findings from this small study are very promising and show the potential for safe stem cell eye surgery as well as improvements in eye repair.

"Our next steps are to better understand how stem cells could promote tissue repair for diseases that are extremely hard to treat and if, and how, they could help to restore vision."

Marc Turner, Medical Director of the Scottish National Blood Transfusion Service and Professor of Cellular Therapy at the University of Edinburgh said: "Clinical studies such as these help us to understand how complex new cellular therapies may be able to complement existing medical approaches in restoring function to damaged tissues and organs."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Stem Cells - Cord Blood Stem Cells - Fundamentals Parkinsons Disease Surgical Treatment Nervous Tic Genetics and Stem Cells Eye Vision LASIK Surgery Facts Allergy Eye Drops Routine Eye Examination 

Recommended Reading
Regenerating Eyes Using Stem Cells from Hair
A young scientist has used stem cells from hair follicles to treat eye surface disease has been ......
Aniridia
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ......
Potential Cure for Aniridia Developed
The potential cure for aniridia, a rare eye disease that limits vision in humans, has now been ......
Research Suggests Nonsense Suppression Drug Restores Function in a Mouse Model of Aniridia
Congenital aniridia is a condition that causes improper development of eye structures as well as ......
Allergy Eye Drops
Eye allergies are treated with different types of eye drops such as lubricants, antihistamines, NSAI...
Nervous Tic
Trigeminal Neuralgia or tic douloureux is one of the most painful nervous system disorders that affe...
Routine Eye Examination
A comprehensive eye exam can take an hour or more, depending on the doctor and the number and comple...
Stem Cells - Fundamentals
Encyclopedia section of medindia gives general info about Stem Cells...
Stem Cells - Cord Blood
Encyclopedia section of medindia gives general info about Cord Blood...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use